Day: May 25, 2020

Leiden, Netherlands & Cambridge, Mass., May 25, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced that the Annual General Meeting of Shareholders will take place on Tuesday, June 23, 2020 at 15:00 CET, via videoconference.All relevant documents and information for the meeting, including the notice and agenda, are or will be made available in the “Investors” section of ProQR’s website (www.proqr.com) under “Financial Information”. The documents will also be made available on the SEC’s website at www.sec.gov.  Shareholders that wish to attend the videoconference should register for attendance as described in the notice and agenda, after which they will receive...

Key points: Biology of Blood and Marrow Transplantation, the official publication of the American Society for Transplantation and Cellular Therapy, publishes three peer-reviewed articles detailing results from three separate trials of remestemcel-L in children and adults with acute graft versus host diseasePublications highlight consistent benefits seen across all three trials in patients with greatest levels of inflammation and the most severe grades of the disease Trial results underpin Mesoblast’s Biologics License Application to seek approval of its product candidate RYONCIL™ (remestemcel-L) for pediatric steroid-refractory acute graft versus host disease (GVHD), which has been accepted for priority review by the United States Food and Drug Administration (FDA)These outcomes also provide the rationale for use of remestemcel-L in other...

Highlights:EarthRenew has developed and produced five new fertilizer formulations for field trials and market development activities this springThe fertilizer formulations incorporate biochar, provided by BiocharNow, as well as insect frassTORONTO, May 25, 2020 (GLOBE NEWSWIRE) — EarthRenew Inc. (CSE:ERTH) (“EarthRenew” or the “Company”) is pleased to announce that it has developed and produced five new formulations of fertilizer pellets, incorporating insect frass and biochar.  We intend to test these new formulations in the field trial programs scheduled to take place this spring in collaboration with Olds College and Lethbridge College (see the Company’s press release dated April 29, 2020, which is available under EarthRenew’s SEDAR profile at www.sedar.com and www.theCSE.com). EarthRenew worked with BiocharNow, LLC (“BiocharNow”)...

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announces that, further to its news release dated May 11, 2020, it has decided to no longer pursue the acquisition of all of the issued and outstanding common shares of Guyana Goldfields Inc.  As a result, Gran Colombia and Gold X Mining Corp. (“Gold X”) have agreed to terminate the Plan of Arrangement between Gran Colombia and Gold X dated May 11, 2020.About Gran Colombia Gold Corp.Gran Colombia is a Canadian-based mid-tier gold producer with its primary focus in Colombia where it is currently the largest underground gold and silver producer with several mines in operation at its high-grade Segovia Operations. Gran Colombia owns approximately 74% of Caldas Gold Corp., a Canadian mining company currently advancing a prefeasibility study for...

Montreal, Quebec,, May 25, 2020 (GLOBE NEWSWIRE) — Montreal, Quebec, May 25th, 2020 – SRG Mining Inc. (TSXV: SRG) (“SRG” or the “Company”) today provides an update on recent activities related to its Lola graphite project (the “Project”).The Company has recently signed its 5th offtake agreement for 10,000 tonnes per year for a three-year period. This brings the total signed off-take agreements to 128,000t over three years. These agreements represent approximately 85% of the Company’s anticipated production over that period. Our clients operate in various markets including refractories, expandable graphite and battery anode material. We remain actively engaged with several potential clients to continue to sign off-take agreements for our graphite production.The Company continues to believe in signing sales agreements for the anticipated...

VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area within its second 1.1 million square foot greenhouse facility in Delta, British Columbia (the “Delta 2 facility”), allowing it to expand capacity as needed through successive license amendments. The Delta 2 facility is adjacent to its established, fully operating 1.1 million square foot Delta 3 greenhouse facility and, when in production, is expected to contribute to further lowering Pure Sunfarms’ already industry leading cost of cultivation.On the heels of the leading market share...

CALGARY, Alberta, May 25, 2020 (GLOBE NEWSWIRE) — (PIPE – TSX-V) Pipestone Energy Corp. (“Pipestone Energy” or the “Company”) announces that it is cancelling the annual and special meeting of shareholders scheduled for June 30, 2020. Once the situation in Alberta has improved such that an in-person meeting can be held in a manner that is safe for the participants, Pipestone Energy will reschedule and hold an annual and special meeting of shareholders.Pipestone Energy will rely on the temporary blanket relief provided by the Canadian Securities Administrators, including exemptive  relief  contained  in Alberta Securities Commission Blanket Order 51-518 – Temporary  Exemptions  from  Certain Requirements to File or Send Securityholder Materials, and will postpone the public filing of its executive compensation disclosure required...

As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.The following transactions have been executed during the period 18 – 20 May 2020:Henceforth, Coloplast owns 3,237,227 treasury B shares of DKK 1 equal to 1,50%...